VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patients
Abstract
Abstract is not available.- journalArticle
- info:eu-repo/semantics/article
- info:eu-repo/semantics/publishedVersion
- Medicine and Health Sciences
- VEGF
- METASTATIC BREAST-CANCER
- MALIGNANT-MELANOMA
- ANGIOGENIC FACTORS
- ANTIBODY BEVACIZUMAB
- WEEKLY PACLITAXEL
- PHASE-2 TRIAL
- A EXPRESSION
- RADIOLABELED BEVACIZUMAB
- Melanoma
- Bevacizumab
- Imaging
- SPECT
- Biomarker
- ENDOTHELIAL GROWTH-FACTOR
- POSITRON-EMISSION-TOMOGRAPHY